Search
for
Sort by
Research 30 of 480
- What does the research say about androgen use and cerebrovascular events?
- Hidradenitis suppurativa and major adverse cardiac events: A systematic review and meta-analysis
- EXPERIENCE WITH ANIFROLUMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH NEUROLOGICAL MANIFESTATIONS
- Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study
- Adverse events associated with vismodegib: insights from a real-world pharmacovigilance study using the FAERS database
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- Reporting on Adverse Clinical Events
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Gender-Affirming Hormone Therapy for Transgender Females
- Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- Drug-Induced Hair Loss: Analysis of the Food and Drug Administration’s Adverse Events Reporting System Database
- Correlation between high hair cortisol level and intracranial aneurysm rupture
- Polycystic ovary syndrome
- Endocrine intervention for transsexuals
- Cardiovascular risk in patients with selected cutaneous diseases
- Cardiovascular Safety Signals of Oral Versus Topical Minoxidil in FAERS: A Disproportionality Analysis (Analytic Cohort 2012–2025)
- Safety and Efficacy Assessment of Red Ginseng Oil (RXGIN) in Men with Lower Urinary Tract Symptoms in a Randomized, Double-Blind, Placebo-Controlled Trial
- Peri-operative Antithrombotic Therapy in Hair Transplantation
- TRANSMEDCON 2022: E-Poster Abstracts
- Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database
- Spectrum and signals of medication-associated cognitive disorder: a comprehensive disproportionality analysis with cross-database validation
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- Polycystic Ovary Syndrome
- Evidence for the efficacy and safety of tadalafil and finasteride in combination for the treatment of lower urinary tract symptoms and erectile dysfunction in men with benign prostatic hyperplasia
- PCSK9: From Nature’s Loss to Patient’s Gain
- Exploring the Interplay between Arsenic and Cutaneous Physiology, Pathology, and Regeneration
- Cutaneous Manifestations of Lupus Erythematosus
- The Rotterdam Study: 2018 update on objectives, design and main results
- Immunological aspects and gender bias during respiratory viral infections including novel Coronavirus disease‐19 (COVID‐19): A scoping review
- Ischemic Stroke in a Young Adult Male During Finasteride Therapy